Convergence of Biotechnology Research
Fundamental to the success of the Michael Smith Laboratories has been the establishment of internationally-recognized research programs. Research conducted at the Michael Smith Laboratories includes the development of the world’s first vaccine to reduce the spread of E. coli by cattle, the decoding of the DNA of tree-killing fungus found in the mouth of mountain pine beetles, and developing innovative drugs to treat chronic pain and other therapies. This research has been made possible by the grants received from provincial and federal programs, partnering organizations, as well as from our generous donors.
The Michael Smith Laboratories is an interdisciplinary unit that brings together biologists and engineers to discover innovative solutions to problems of societal importance. The chart below shows how our faculty members fall into four clusters based on their research keywords. Through these clusters, they work on research questions to effectively address significant issues in today’s world.